These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26159556)

  • 61. Btk Inhibitor RN983 Delivered by Dry Powder Nose-only Aerosol Inhalation Inhibits Bronchoconstriction and Pulmonary Inflammation in the Ovalbumin Allergic Mouse Model of Asthma.
    Phillips JE; Renteria L; Burns L; Harris P; Peng R; Bauer CM; Laine D; Stevenson CS
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):233-41. PubMed ID: 27111445
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin.
    Ando M; Murakami Y; Kojima F; Endo H; Kitasato H; Hashimoto A; Kobayashi H; Majima M; Inoue M; Kondo H; Kawai S; Hayashi I
    Am J Respir Cell Mol Biol; 2003 May; 28(5):582-91. PubMed ID: 12707014
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The significant effect of chronic intermittent hypoxia on prostaglandin D
    Shan LN; Chai WS; Lu SJ; Song YG; Su D; Yang S; Shi XB; Wang W
    Biochem Biophys Res Commun; 2017 Jan; 483(1):283-287. PubMed ID: 28025147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sustained expression of lipocalin-type prostaglandin D synthase in the antisense direction positively regulates adipogenesis in cloned cultured preadipocytes.
    Chowdhury AA; Hossain MS; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    Biochem Biophys Res Commun; 2011 Jul; 411(2):287-92. PubMed ID: 21726533
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.
    Zayed N; Afif H; Chabane N; Mfuna-Endam L; Benderdour M; Martel-Pelletier J; Pelletier JP; Motiani RK; Trebak M; Duval N; Fahmi H
    Arthritis Rheum; 2008 Nov; 58(11):3530-40. PubMed ID: 18975308
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides.
    Mohri I; Taniike M; Okazaki I; Kagitani-Shimono K; Aritake K; Kanekiyo T; Yagi T; Takikita S; Kim HS; Urade Y; Suzuki K
    J Neurochem; 2006 May; 97(3):641-51. PubMed ID: 16515539
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stable expression of lipocalin-type prostaglandin D synthase in cultured preadipocytes impairs adipogenesis program independently of endogenous prostanoids.
    Hossain MS; Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Shono F; Yokota K
    Exp Cell Res; 2012 Feb; 318(4):408-15. PubMed ID: 22100987
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enhancement of prostaglandin D(2) production through cyclooxygenase-2 and lipocalin-type prostaglandin D synthase by upstream stimulatory factor 1 in human brain-derived TE671 cells under serum starvation.
    Fujimori K; Aritake K; Urade Y
    Gene; 2008 Dec; 426(1-2):72-80. PubMed ID: 18817855
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of hematopoietic prostaglandin D2 synthase (H-PGDS) by an alkaloid extract from Combretum molle.
    Moyo R; Chimponda T; Mukanganyama S
    BMC Complement Altern Med; 2014 Jul; 14():221. PubMed ID: 24996417
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells.
    Kawata R; Reddy ST; Wolner B; Herschman HR
    J Immunol; 1995 Jul; 155(2):818-25. PubMed ID: 7608559
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors.
    Deaton DN; Do Y; Holt J; Jeune MR; Kramer HF; Larkin AL; Orband-Miller LA; Peckham GE; Poole C; Price DJ; Schaller LT; Shen Y; Shewchuk LM; Stewart EL; Stuart JD; Thomson SA; Ward P; Wilson JW; Xu T; Guss JH; Musetti C; Rendina AR; Affleck K; Anders D; Hancock AP; Hobbs H; Hodgson ST; Hutchinson J; Leveridge MV; Nicholls H; Smith IED; Somers DO; Sneddon HF; Uddin S; Cleasby A; Mortenson PN; Richardson C; Saxty G
    Bioorg Med Chem; 2019 Apr; 27(8):1456-1478. PubMed ID: 30858025
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prostaglandin D synthase: structure and function.
    Urade Y; Hayaishi O
    Vitam Horm; 2000; 58():89-120. PubMed ID: 10668396
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mast Cell-Specific Deletion of Group III Secreted Phospholipase A
    Taketomi Y; Endo Y; Higashi T; Murase R; Ono T; Taya C; Kobayashi T; Murakami M
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359862
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Therapeutic Potential of Hematopoietic Prostaglandin D
    Rittchen S; Heinemann A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31226822
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hematopoietic-Prostaglandin D2 synthase through PGD2 production is involved in the adult ovarian physiology.
    Farhat A; Philibert P; Sultan C; Poulat F; Boizet-Bonhoure B
    J Ovarian Res; 2011 Feb; 4():3. PubMed ID: 21352547
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Therapeutic potential of D prostanoid receptor 1 signal enhancement in a murine model of food allergy.
    Nakamura T; Hirai R; Tachibana Y; Masuko S; Nagata N; Murata T
    J Allergy Clin Immunol; 2019 Jun; 143(6):2290-2293.e4. PubMed ID: 30902371
    [No Abstract]   [Full Text] [Related]  

  • 77. [New aspects on prostaglandin D synthases].
    Urade Y
    Nihon Yakurigaku Zasshi; 1997 Oct; 110 Suppl 1():56P-58P. PubMed ID: 9503406
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-quality crystals of human haematopoietic prostaglandin D synthase with novel inhibitors.
    Takahashi S; Tsurumura T; Aritake K; Furubayashi N; Sato M; Yamanaka M; Hirota E; Sano S; Kobayashi T; Tanaka T; Inaka K; Tanaka H; Urade Y
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Jul; 66(Pt 7):846-50. PubMed ID: 20606289
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer.
    Yokoo H; Shibata N; Naganuma M; Murakami Y; Fujii K; Ito T; Aritake K; Naito M; Demizu Y
    ACS Med Chem Lett; 2021 Feb; 12(2):236-241. PubMed ID: 33603969
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Aspirin-exacerbated Respiratory Disease: A Syndrome of Mast Cell-mediated PgD2 Overproduction.
    Borish L
    Am J Respir Crit Care Med; 2019 Sep; 200(6):651-652. PubMed ID: 31026400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.